Uncategorized

Outside the Box: Active managers see value in these 3 company practices but indexers hate them. Who’s right?

Every corporation is unique. It follows that governance arrangements should be tailored to suit. Yet many shareholders, especially indexers, roundly condemn certain governance practices as if one size fits all.  Three corporate practices illustrate this: combining the roles of chairman and chief executive; staggered director terms, and classes of stock with different voting rights. Each… Continue reading Outside the Box: Active managers see value in these 3 company practices but indexers hate them. Who’s right?

Uncategorized

WHO’s Tedros dismisses Ethiopian allegations of war bias

The director-general of the World Health Organisation has dismissed allegations that he is “taking sides” in the war in his native Ethiopia as untrue. Ethiopia’s army chief has accused Tedros Adhanom Ghebreyesus, an ethnic Tigrayan and arguably one of the world’s best known Ethiopians, of attempting to secure weapons and backing for leaders of the… Continue reading WHO’s Tedros dismisses Ethiopian allegations of war bias

Uncategorized

What is a poll watcher and who’s allowed to be one on Election Day? Not just anyone

The first presidential debate was full of cross talk, incomplete answers and unfinished statements, but President Donald Trump made one thing clear: he wants his backers keeping a close eye on polling places. “I’m urging my supporters to go into the polls and watch very carefully because that’s what has to happen,” he said. More… Continue reading What is a poll watcher and who’s allowed to be one on Election Day? Not just anyone

Uncategorized

EU medicine regulator seeks full results of WHO’s remdesivir trial

The EU’s medicines regulator has requested the complete results of the World Health Organization’s remdesivir trial, the European Commission said, after the study found the Covid-19 treatment to have no substantial effect on rates of survival. The European Commission announced last week that it had signed a deal with the developer, Gilead Sciences, to supply… Continue reading EU medicine regulator seeks full results of WHO’s remdesivir trial

Business news

Lockdown sceptics v zero-Covid: who’s got it right?

Covid in the UK has not been as polarized as Brexit or the US political landscape. But it’s quite polarized. At one extreme are the zero Covid proponents; on the other, the skeptics of the lockout. Who is right? Some lockout skeptics have put forward a variety of dishonest or deceived views during the pandemic.… Continue reading Lockdown sceptics v zero-Covid: who’s got it right?

Uncategorized

The Tell: That stock-market storm investors are so worried about? It’s already here, warns fund manager who’s returned 50% so far this year

Are lumber prices signaling trouble ahead? Patrick Smith/Getty Images Tiiimber? Michael Gayed, the man behind the risk-on, risk-off ATAC Rotation Fund ATCIX, and its whopping 50% return this year, is sounding the alarm on lumber prices and what they could mean for the broader stock market. “Nearly every major correction, crash, and bear market has… Continue reading The Tell: That stock-market storm investors are so worried about? It’s already here, warns fund manager who’s returned 50% so far this year

Uncategorized

Who’s hiding behind SoftBank’s hedge?

US tech stocks currently look like snapping a three-session losing streak, but shares in Japan’s SoftBank, which has been implicated in stoking this year’s big rally, fell as much as 7 per cent in Tokyo today. Its shareholders are now calling on the tech conglomerate to reveal who is running the asset management unit that… Continue reading Who’s hiding behind SoftBank’s hedge?

Business news

‘Vaccine nationalism’ delays WHO’s struggling Covax scheme

The World Health Organization was forced to rethink its global Covid 19 vaccine purchasing facility, after rich nations were slow to register and instead sought bilateral agreements. Governments were told last week that the deadline for joining the so-called Covax program had been extended from Aug.31 to Sept.18, according to documents seen by the Financial… Continue reading ‘Vaccine nationalism’ delays WHO’s struggling Covax scheme